Bailard’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,743
Closed -$91K 803
2022
Q1
$91K Buy
+7,743
New +$91K ﹤0.01% 698